Abstract
Since its discovery in early 1980s to date, our knowledge about CRISPR
has evoloved so much. CRISPR/Cas system confers the immunization ability
against phages to the bacteria and is comprised of three stages:
acquisition, biogenesis, and interference. It was first in 2012 when
Charpentier and Doudna proposed Cas9 enzyme as a novel gene editing
tool. They opened a new gate on the way of gene editing which led to new
discoveries as well as novel treatments for diseases. It must be taken
into consideration that the delivery of CRISPR/Cas9 remains a great
barrier on the way of mass clinical exploition. The delivery of
CRISPR/Cas9 requires a cargo and a vehicle. There are three types of
cargos: plasmids, mRNAs, and enzymes. There two main types of vehicles
as well: viral and non-viral. Non-viral delivery can be subdivided into
physical and various nanoparticle mediated delivery. In this systematic
review, we aimed to give an overall insight to the all delivery methods
used for the delivery of CRISPR/Cas9 used for gene editing both in-vitro
and in-vivo. We conducted a thorough search from two databases: Medline
and scopus. After the screening Process we found 77 eligible papers and
the results are illustrated in table 1,2, and 3.